BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25592121)

  • 1. Unintentional secondary exogenous corticosteroid exposure and central serous chorioretinopathy.
    Thinda S; Lam K; Park SS
    Eye (Lond); 2015 Apr; 29(4):577-9. PubMed ID: 25592121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.
    Chang YS; Weng SF; Chang C; Wang JJ; Wang JY; Jan RL
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4083-9. PubMed ID: 26114485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serous chorioretinopathy, corticosteroids, and uveitis.
    Khairallah M; Kahloun R; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
    Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
    Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
    Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
    Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 30-Year-Old Man with a Recent History of COVID-19 Requiring Treatment with Corticosteroids Who Developed Bilateral Central Serous Chorioretinopathy During 7-Month Follow-Up.
    Angelidis CD; Georgalas I; Giachos I; Symeonidis C; Mani A; Rotsos T
    Am J Case Rep; 2023 Nov; 24():e940241. PubMed ID: 38007612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.
    Tsai DC; Chen SJ; Huang CC; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Chen TJ; Leu HB
    Retina; 2014 Sep; 34(9):1867-74. PubMed ID: 24743638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.
    Kleinberger AJ; Patel C; Lieberman RM; Malkin BD
    Laryngoscope; 2011 Sep; 121(9):2034-7. PubMed ID: 22024860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.
    Chang YS; Weng SF; Wang JJ; Jan RL
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central serous chorioretinopathy following kidney transplantation.
    Farzan K; Rezaei L; Ghanbari H; Dehghani A
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):615-20. PubMed ID: 24821161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases.
    Valls Pascual E; Martínez-Costa L; Santander F
    BMC Musculoskelet Disord; 2015 Dec; 16():378. PubMed ID: 26638151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.
    Nakatsuka AS; Khanamiri HN; Lam QN; El-Annan J
    Hawaii J Med Public Health; 2019 May; 78(5):151-154. PubMed ID: 31049263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
    Shin YU; Lee BR
    Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.
    Dağ U; Çağlayan M; Öncül H; Alakuş MF
    Int Ophthalmol; 2020 Nov; 40(11):3155-3161. PubMed ID: 32671599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central serous chorioretinopathy after nasal corticosteroids in the aviator.
    Ben Salem S; Sithom A; Ben Dhia I; Khelifi T; Askri H; Ayed A
    Tunis Med; 2016 Nov; 94(11):695. PubMed ID: 28994874
    [No Abstract]   [Full Text] [Related]  

  • 16. The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory disease.
    Gupta SR; Suhler EB; Rosenbaum JT
    J Rheumatol; 2010 Sep; 37(9):1973-4. PubMed ID: 20810529
    [No Abstract]   [Full Text] [Related]  

  • 17. Central serous chorioretinopathy after nasal corticosteroids in the aviator.
    Ben Salem S; Sithom A; Ben Dhia I; Khelifi T; Askri H; Ayed A
    Tunis Med; 2016 Dec; 94(12):893. PubMed ID: 28994894
    [No Abstract]   [Full Text] [Related]  

  • 18. The adverse effects of corticosteroids in central serous chorioretinopathy.
    De Nijs E; Brabant P; De Laey JJ
    Bull Soc Belge Ophtalmol; 2003; (289):35-41. PubMed ID: 14619628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
    Ezra N; Taban M; Behroozan D
    J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.
    Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Leu HB
    Acta Ophthalmol; 2013 Nov; 91(7):666-71. PubMed ID: 22998678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.